Resumo

TORRES ZAFRA, Javier Francisco  e  PERREZ ROMERO, Germán Enrique. Safety and efficacy of tenecteplase in acute ischemia stroke a narrative review. Acta Neurol Colomb. [online]. 2020, vol.36, n.2, pp.110-115. ISSN 0120-8748.  https://doi.org/10.22379/24224022286.

Alteplase is the only one fibrinolytic currently authorized in Colombia for the treatment of acute ischemic stroke. Tenecteplase constitutes a new treatment alternative in this disease by offering a better pharmacological profile, greater efficacy with better outcomes: like higher recanalization percentages and with similar safety profile. The possibility of a temporary shortage of alteplase with availability of tenecteplase in Colombia opens the possibility of its use in acute ischemic stroke.

Palavras-chave : stroke; ischemic stroke; thrombolytic therapy; intravenous thrombolysis; intracranial hemorrhage (MeSH).

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )